Home › Prostate Cancer › North Carolina › Asheville
Prostate Cancer clinical trials in Asheville, NC
3 studies for Prostate Cancer are looking for participants at sites in and around Asheville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- AdventHealth Infusion Center Asheville, Asheville
- AdventHealth Infusion Center Weaverville, Weaverville · 7 mi away
- AdventHealth Hendersonville, Hendersonville · 20 mi away
- and 1 more
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Margaret R Pardee Memorial Hospital, Hendersonville · 20 mi away
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- Margaret R Pardee Memorial Hospital, Hendersonville · 20 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN43 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Asheville
- Heart Failure7 studies
- Non-Small Cell Lung Cancer5 studies
- Acute Lymphoblastic Leukemia4 studies
- Acute Myeloid Leukemia4 studies
- Chronic Lymphocytic Leukemia4 studies
- Burkitt Lymphoma4 studies
- Cardiovascular Disease4 studies
- Lung Cancer4 studies
- Acute Biphenotypic Leukemia3 studies
- Melanoma3 studies
- Graves Disease3 studies
- Hyperthyroidism3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.